Fenofibrate, a ligand for PPARα, inhibits aromatase cytochrome P450 expression in the ovary of mouse
Authors:
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (2) , 265-270
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor αEndocrinology, 2002
- Effect of a peroxisome proliferator on 3β-hydroxysteroid dehydrogenaseBiochemical and Biophysical Research Communications, 2002
- Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administrationHepatology Research, 2002
- Increasing high-density lipoprotein cholesterol: an update on fenofibrateThe American Journal of Cardiology, 2001
- Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17β-estradiol or a peroxisome proliferatorThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- The role of fibric acids in atherosclerosisCurrent Atherosclerosis Reports, 2001
- PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the LiverBiochemical and Biophysical Research Communications, 2000
- Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient miceJournal of Clinical Investigation, 2000
- Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function.Endocrinology, 1994
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990